Clinical Trials Browser

Phase 1 × azeliragon × 90 days × Clear all

NCT06724926 2026-01-02

Concurrent Azeliragon With Craniospinal Irradiation

Phase 1 Recruiting

Glioma, Meningeal Carcinomatosis